Skip Navigation
National Cancer Institute

Webinar: Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery

May 9, 2017 (1 – 2 p.m. EDT)

Register Now exit disclaimer

Questions can be posed in advance to ncidccpsbrpadvances@mail.nih.gov.

This webinar will provide an overview of the R01 and R21 funding opportunity announcements, Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-17-060 (R01) and PA-17-061 (R21).

These funding opportunities seek research to:

  1. assess and describe the current state of oral anticancer medication utilization, delivery, and adherence;
  2. identify structural, systemic, and psychosocial barriers to adherence; and
  3. develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.

National Cancer Institute Speakers:

Wendy Nelson
Wendy Nelson, Ph.D.
Program Director
Basic Biobehavioral and Psychological Sciences Branch
Behavioral Research Program
Kelly filipski
Kelly Filipski, Ph.D., M.P.H.
Program Director
Clinical and Translational Epidemiology Branch
Epidemiology and Genomics Research Program
Kathleen castro
Kathleen Castro, RN, MS, AOCN®
Program Director
Office of the Associate Director
Healthcare Delivery Research Program

Intended Audience: Extramural investigators at junior, mid-, and senior levels.

Email your questions in advance to ncidccpsbrpadvances@mail.nih.gov. Questions about specific aims or grant application details will not be addressed.

Visit the archive page to view other Scientific News from the Behavioral Research Program newsletters.